Get the Stockscreener App
4.20
1.69%
0.07
Mimedx Group Inc stock is traded at $4.20, with a volume of 531.89K.
It is up +1.69% in the last 24 hours and up +9.66% over the past month.
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
See More
Previous Close:
$4.13
Open:
$4.17
24h Volume:
531.89K
Relative Volume:
0.37
Market Cap:
$625.57M
Revenue:
$389.42M
Net Income/Loss:
$30.70M
P/E Ratio:
20.56
EPS:
0.2043
Net Cash Flow:
$67.23M
1W Performance:
-2.33%
1M Performance:
+9.66%
6M Performance:
-20.15%
1Y Performance:
-38.69%
1-Day Range:
$4.14
$4.23
1-Week Range:
$4.09
$4.35
52-Week Range:
$3.025
$7.99
Mimedx Group Inc Stock (MDXG) Company Profile
Name
Mimedx Group Inc
Sector
Industry
Phone
(770) 651-9100
Address
1775 W OAK COMMONS COURT, NE, MARIETTA
Compare MDXG vs PSNYW, GOODO, SHMD, DWLD, QQQE
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| 6.49 | 0 | 0 | 0 | 0 | 0.00 | |
PSNYW
Polestar Automotive Holding Uk
|
2.79 | 404.28M | 2.07B | -1.42B | -1.37B | -0.6765 |
GOODO
Gladstone Commercial Corporation
|
20.39 | 372.90M | 0 | 0 | 0 | 0.00 |
SHMD
Schmid Group N V
|
4.115 | 270.26M | 52.15M | -21.46M | 0 | -0.4675 |
DWLD
Davis Select Worldwide ETF
|
46.71 | 0 | 0 | 0 | 0 | 0.00 |
QQQE
Direxion NASDAQ-100 Equal Weigh
|
115.41 | 0 | 0 | 0 | 0 | 0.00 |
Mimedx Group Inc Stock (MDXG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-23-26 | Initiated | Citizens | Mkt Outperform |
| Jul-02-24 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-07-24 | Initiated | Lake Street | Buy |
| Oct-27-23 | Initiated | Craig Hallum | Buy |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Jul-26-21 | Initiated | Northland Capital | Outperform |
| Mar-19-21 | Initiated | H.C. Wainwright | Buy |
View All
Mimedx Group Inc Stock (MDXG) Latest News
MiMedx Group, Inc (MDXG) Investor Outlook: Exploring a 52.42% Potential Upside Amidst Biotech Innovations - DirectorsTalk Interviews
MIMEDX will review second-quarter results in a July 29 webcast - Stock Titan
MiMedx Group (MDXG) Cantor Global Healthcare Conference 2025 Summary - Quartr
Form 4 MiMedx Group Inc For: 7 July By Investing.com - Investing.com Nigeria
MIMEDX (MDXG) CFO has shares withheld to cover RSU tax liability - Stock Titan
MiMedx Group, Inc.(NasdaqCM:MDXG) dropped from Russell Small Cap Comp Growth Benchmark - marketscreener.com
MiMedx Group, Inc.(NasdaqCM: MDXG) dropped from Russell 2500 Growth Benchmark - marketscreener.com
MiMedx Group, Inc.(NasdaqCM: MDXG) added to Russell 2000 Value Benchmark - marketscreener.com
MiMedx Group, Inc.(NasdaqCM: MDXG) added to Russell Microcap Value Benchmark Index - marketscreener.com
MiMedx Group, Inc.(NasdaqCM: MDXG) dropped from Russell 2000 Growth Benchmark - marketscreener.com
MiMedx Group, Inc.(NasdaqCM: MDXG) dropped from Russell 3000E Growth Benchmark - marketscreener.com
MiMedx Group, Inc.(NasdaqCM: MDXG) added to Russell 2000 Value-Defensive Index - marketscreener.com
MDXGMimedx Group Inc Latest SEC Filings - Finviz
MiMedx Group, Inc.(NasdaqCM: MDXG) added to Russell 2500 Value Benchmark - marketscreener.com
Enterprise value to EBIT forward of MiMedx Group, Inc – NASDAQ:MDXG - TradingView
Enterprise value to EBIT forward of MiMedx Group, Inc – BOATS:MDXG - TradingView
Price to earnings forward of MiMedx Group, Inc – NASDAQ:MDXG - TradingView
Enterprise value to EBITDA forward of MiMedx Group, Inc – NASDAQ:MDXG - TradingView
Price to earnings forward of MiMedx Group, Inc – BOATS:MDXG - TradingView
Enterprise value to revenue forward of MiMedx Group, Inc – NASDAQ:MDXG - TradingView
Enterprise value to revenue forward of MiMedx Group, Inc – BOATS:MDXG - TradingView
Price to book forward of MiMedx Group, Inc – BOATS:MDXG - TradingView
Price to sales forward of MiMedx Group, Inc – NASDAQ:MDXG - TradingView
Price to sales forward of MiMedx Group, Inc – BOATS:MDXG - TradingView
MiMedx Group, Inc. Actuals & Estimates (NASDAQ:MDXG) - TradingView
MiMedx Group, Inc. Actuals & Estimates (BOATS:MDXG) - TradingView
MIMEDX (MDXG) CCO sees 19,820 shares withheld to cover tax on RSU vesting - Stock Titan
MDXG Forecast — Price Target — Prediction for 2027 - TradingView
MiMedx Group Inc (MDXG) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Is the options market predicting a spike in MiMedx Group stock? - MSN
MiMedx Group (MDXG) Stock Faces Mixed Analyst Target Changes After Guidance Cut - Yahoo Finance
MiMedx Group StockAnalyst and consensus snapshot after quiet news day - AD HOC NEWS
Craig-Hallum Sticks to Their Buy Rating for MiMedx Group (MDXG) - The Globe and Mail
MiMedx Group Inc (MDXG) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
MiMedx Group Inc (MDXG) Institutional Confidence - TradingKey
MiMedx Group Inc (MDXG) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
MiMedx Group Inc (MDXG) Valuation: PE, PB & Fair Value Analysis - TradingKey
MiMedx Group Inc (MDXG) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
MiMedx Group Inc (MDXG) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
MiMedx Group Inc (MDXG) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
MiMedx Group Inc (MDXG) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
MiMedx Shareholders Back Board, Pay and Bylaw Changes - The Globe and Mail
MiMedx Group (MDXG) Slips 2.43% as Traders Eye Key Support at $3.43Wide Range Bar - dars.gov.et
MiMedx (NASDAQ: MDXG) details bylaw change and 2026 shareholder votes - Stock Titan
MiMedx (NASDAQ: MDXG) awards 50,913 restricted shares to director - Stock Titan
Director Dorothy Puhy granted 50,913 MDXG shares in annual stock award - Stock Titan
MIMEDX (NASDAQ: MDXG) awards 50,913 restricted shares to director Todd Newton - Stock Titan
MIMEDX (MDXG) director William Hawkins receives 50,913-share restricted stock grant - Stock Titan
MiMedx (NASDAQ: MDXG) director Tiffany Olson receives 50,913-share stock grant - Stock Titan
MiMedx Group (MDXG) AGM 2026 Summary - Quartr
How The MiMedx Group (MDXG) Story Is Shifting As Analysts Rework Price Targets - Yahoo Finance
Mimedx Group Inc Stock (MDXG) Financials Data
Revenue
Net Income
Cash Flow
EPS
Mimedx Group Inc Stock (MDXG) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Hulse William Frank IV | General Counsel and CAO |
Mar 10 '26 |
Option Exercise |
4.50 |
136,364 |
613,638 |
624,900 |
| DOUG RICE | Chief Financial Officer |
Mar 10 '26 |
Option Exercise |
4.50 |
243,000 |
1,093,500 |
508,678 |
| Maersk-Moller Kimberly | Chief Commercial Officer |
Nov 06 '25 |
Sale |
7.42 |
58,300 |
432,329 |
236,982 |
0.46%
0.84%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):